BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 29868486)

  • 1. Clinical Results of Mean GTV Dose Optimized Robotic-Guided Stereotactic Body Radiation Therapy for Lung Tumors.
    Baumann R; Chan MKH; Pyschny F; Stera S; Malzkuhn B; Wurster S; Huttenlocher S; Szücs M; Imhoff D; Keller C; Balermpas P; Rades D; Rödel C; Dunst J; Hildebrandt G; Blanck O
    Front Oncol; 2018; 8():171. PubMed ID: 29868486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases.
    Andratschke N; Parys A; Stadtfeld S; Wurster S; Huttenlocher S; Imhoff D; Yildirim M; Rades D; Rödel CM; Dunst J; Hildebrandt G; Blanck O
    Radiat Oncol; 2016 May; 11():74. PubMed ID: 27236333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breathing-motion-compensated robotic guided stereotactic body radiation therapy : Patterns of failure analysis.
    Stera S; Balermpas P; Chan MKH; Huttenlocher S; Wurster S; Keller C; Imhoff D; Rades D; Dunst J; Rödel C; Hildebrandt G; Blanck O
    Strahlenther Onkol; 2018 Feb; 194(2):143-155. PubMed ID: 28875297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic Robotic Body Radiotherapy for Patients With Unresectable Hepatic Oligorecurrence.
    Berkovic P; Gulyban A; Nguyen PV; Dechambre D; Martinive P; Jansen N; Lakosi F; Janvary L; Coucke PA
    Clin Colorectal Cancer; 2017 Dec; 16(4):349-357.e1. PubMed ID: 28462852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single community-based institutional series of stereotactic body radiation therapy (SBRT) for treatment of liver metastases.
    Anstadt EJ; Shumway R; Colasanto J; Grew D
    J Gastrointest Oncol; 2019 Apr; 10(2):330-338. PubMed ID: 31032102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver SBRT with active motion-compensation results in excellent local control for liver oligometastases: An outcome analysis of a pooled multi-platform patient cohort.
    Stera S; Miebach G; Buergy D; Dreher C; Lohr F; Wurster S; Rödel C; Marcella S; Krug D; Frank A G; Ehmann M; Fleckenstein J; Blanck O; Boda-Heggemann J
    Radiother Oncol; 2021 May; 158():230-236. PubMed ID: 33667585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors.
    Parker SM; Siochi RA; Wen S; Mattes MD
    Pract Radiat Oncol; 2019 Jan; 9(1):e90-e97. PubMed ID: 30267899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 4D dose to a moving target with Monte Carlo dose calculation in stereotactic body radiotherapy for lung cancer.
    Matsugi K; Nakamura M; Miyabe Y; Yamauchi C; Matsuo Y; Mizowaki T; Hiraoka M
    Radiol Phys Technol; 2013 Jan; 6(1):233-40. PubMed ID: 23247576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric evaluation of target coverage as a predictor of local failure following stereotactic body radiation therapy for spinal tumors.
    Jawad MS; Zhou J; Harb JG; Wilkinson JB; Prausa SK; Wloch J; Krauss DJ; Fahim D; Yan D; Grills IS
    J Radiosurg SBRT; 2015; 3(3):225-235. PubMed ID: 29296405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.
    Yamada Y; Katsoulakis E; Laufer I; Lovelock M; Barzilai O; McLaughlin LA; Zhang Z; Schmitt AM; Higginson DS; Lis E; Zelefsky MJ; Mechalakos J; Bilsky MH
    Neurosurg Focus; 2017 Jan; 42(1):E6. PubMed ID: 28041329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance.
    Kestin L; Grills I; Guckenberger M; Belderbos J; Hope AJ; Werner-Wasik M; Sonke JJ; Bissonnette JP; Xiao Y; Yan D;
    Radiother Oncol; 2014 Mar; 110(3):499-504. PubMed ID: 24630539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry's experience.
    Ricco A; Davis J; Rate W; Yang J; Perry D; Pablo J; D'Ambrosio D; Sharma S; Sundararaman S; Kolker J; Creach KM; Lanciano R
    Radiat Oncol; 2017 Feb; 12(1):35. PubMed ID: 28143558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant Correlation Between Overall Survival and Mean Lung Dose in Lung Stereotactic Body Radiation Therapy (SBRT).
    Dupic G; Biau J; Molnar I; Chassin V; Dedieu V; Lapeyre M; Bellière-Calandry A
    Front Oncol; 2020; 10():1577. PubMed ID: 32850462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose coverage impacts local control in ultra-central lung oligometastases treated with stereotactic radiotherapy.
    Loi M; Franceschini D; Dominici L; Chiola I; Franzese C; D'Agostino GR; Navarria P; Marzo M; Paganini L; Comito T; Mancosu P; Tomatis S; Cozzi L; Alifano M; Scorsetti M
    Strahlenther Onkol; 2021 May; 197(5):396-404. PubMed ID: 32970163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CyberKnife
    Oudin V; Salleron J; Marchesi V; Peiffert D; Khadige M; Faivre JC
    J Thorac Dis; 2023 Sep; 15(9):4636-4647. PubMed ID: 37868838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic ablative body radiotherapy with a central high dose using CyberKnife for metastatic lung tumors.
    Hayashi K; Suzuki O; Shiomi H; Ono H; Setoguchi A; Nakai M; Nakanishi E; Tatekawa S; Ose N; Hirata T; Tamari K; Seo Y; Funaki S; Isohashi F; Shimizu S; Shintani Y; Ogawa K
    BMC Cancer; 2023 Mar; 23(1):215. PubMed ID: 36882702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of liver metastasis volume in breast cancer patients treated with stereotactic body radiotherapy.
    Oymak E; Guler OC; Onal C
    Strahlenther Onkol; 2022 Mar; 198(3):247-253. PubMed ID: 34477885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of respiratory motion management technique on radiation pneumonitis risk with robotic stereotactic body radiation therapy.
    Chapman CH; McGuinness C; Gottschalk AR; Yom SS; Garsa AA; Anwar M; Braunstein SE; Sudhyadhom A; Keall P; Descovich M
    J Appl Clin Med Phys; 2018 Jul; 19(4):48-57. PubMed ID: 29700954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiotherapy of adrenal metastases-A dose-finding study.
    Buergy D; Würschmidt F; Gkika E; Hörner-Rieber J; Knippen S; Gerum S; Balermpas P; Henkenberens C; Voglhuber T; Kornhuber C; Barczyk S; Röper B; Rashid A; Blanck O; Wittig A; Herold HU; Brunner TB; Sweeney RA; Kahl KH; Ciernik IF; Ottinger A; Izaguirre V; Putz F; König L; Hoffmann M; Combs SE; Guckenberger M; Boda-Heggemann J
    Int J Cancer; 2022 Aug; 151(3):412-421. PubMed ID: 35383919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.